Ahmet Kasim Kilic

Ahmet Kasim Kilic

Auto-generated profile, based on publicly available information

Ahmet Kasim Kilic

Department of Neurology, University of Health Sciences, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
AKAhmet Kasim Kilic
Ahmet Kasim Kilic
ASAysegul Akkan Suzan
Aysegul Akkan Suzan
ABAnil Bulut
Anil Bulut
FŞFatma Gülhan Şahbaz
Fatma Gülhan Şahbaz
Teriflunomide is an oral medication approved for the treatment of patients with multiple sclerosis. The primary effect of teriflunomide is to reduce de novo pyrimidine synthesis by inhibiting mitochondrial dihydroorotate dehydrogenase, thereby causing cell-cycle arrest. We aimed to investigate the occurrence of peripheral neuropathy, a rare side effect of teriflunomide, in patients receiving teriflunomide.

3 June 2024 in Balkan Medical Journal
Verified
Journal Article
Open access
SKSumeyye Koc
Sumeyye Koc
SŞSedat Şen
Sedat Şen
YTYüksel Terzi
Yüksel Terzi
FKFerah Kızılay
Ferah Kızılay
SDSerkan Demir
Serkan Demir
MTMurat Terzi
Murat Terzi
Optic neuritis, myelitis, and neuromyelitis optica spectrum disorder (NMOSD) have been associated with antibodies against myelin oligodendrocyte glycoprotein-immunoglobulin G (anti-MOG-IgG). Furthermore, patients with radiological and demographic features atypical for multiple sclerosis (MS) with optic neuritis and myelitis also demonstrate antibodies against aquaporin-4 and anti-MOG-IgG. However, data on the diagnosis, treatment, follow-up, and prognosis in patients with anti-MOG-IgG are limited. To evaluate the clinical, radiological, and demographic characteristics of patients with anti-MOG-IgG. Multicenter, retrospective, observational study. Patients with blood samples demonstrating anti-MOG-IgG that had been evaluated at the Neuroimmunology laboratory at Ondokuz Mayıs University's Faculty of Medicine were included in the study. Of the 104 patients with anti-MOG-IgG, 56.7% were women and 43.3% were men. Approximately 2.4% of the patients were diagnosed with MS, 15.8% with acute disseminated encephalomyelitis (ADEM), 39.4% with NMOSD, 31.3% with isolated optic neuritis, and 11.1% with isolated myelitis. Approximately 53.1% of patients with spinal involvement at clinical onset demonstrated a clinical course of NMOSD. Thereafter, 8.8% of these patients demonstrated a clinical course similar to MS and ADEM, and 28.1% demonstrated a clinical course of isolated myelitis. The response to acute attack treatment was lower and the disability was higher in patients aged > 40 years than patients aged < 40 years at clinical onset. Oligoclonal band was detected in 15.5% of the patients. For patients with NMOSD and without anti-NMO antibodies, the diagnosis is supported by the presence of anti-MOG-IgG. Furthermore, advanced age at clinical onset, Expanded Disability Status Scale (EDSS) score at clinical onset, spinal cord involvement, and number of attacks may be negative prognostic factors in patients with anti-MOG-IgG.

1 January 2012 in Journal of Cardiac Surgery
Verified
Journal Article
Open access
PDF file
MSMatthew L. Stone
Matthew L. Stone
AKAhmet Kilic
Ahmet Kilic
JKJamie L.W. Kennedy
Jamie L.W. Kennedy
JBJames D. Bergin
James D. Bergin
JKJohn A. Kern
John A. Kern
We report the first documented case of HeartMate II® left ventricular assist device (LVAD) reimplantation following Cohn Teflon felt plug repair of the initial left ventricular apical cannulation site. This case highlights the current limitations of the predictability of myocardial recovery while describing an effective technique for possible future LVAD reimplantation.

29 March 2022 in Turkish Journal Of Neurology
Verified
Journal Article
Open access
AKAhmet Kasım Kılıç
Ahmet Kasım Kılıç
TKTuğçe Kara
Tuğçe Kara
BBBanu Özen Barut
Banu Özen Barut

18 September 2026 in BMC Neurology
Verified
Journal Article
Open access
PDF file
EHEmine Avcı Hüseyinoğlu
Emine Avcı Hüseyinoğlu
AKAhmet Kasim Kilic
Ahmet Kasim Kilic
MTMehmet Engin Tezcan
Mehmet Engin Tezcan
NSNesrin Sen
Nesrin Sen
RIRahsan Adviye Inan
Rahsan Adviye Inan
In primary Sjögren’s Syndrome (pSS), neurologic involvement is not uncommon. We aim to determine the frequency of central and/or peripheral neur

22 September 2023 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
EÇEmine Çalışkan
Emine Çalışkan
SŞsafiye güneş şentürk
safiye güneş şentürk
UYUfuk Yukselmis
Ufuk Yukselmis
AKAhmet Kasim Kilic
Ahmet Kasim Kilic
HGHediye Pınar Gunbey
Hediye Pınar Gunbey